Publications by authors named "Christopher Subasic"

Claim this Profile
L
Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity.
Gayathri R Ediriweera, Neville J Butcher, Ashok Kothapalli, Jiacheng Zhao, Joanne T Blanchfield, Christopher N Subasic

Biomater Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A PEGylated liposomal formulation of prochlorperazine that limits brain exposure but retains dynamin II activity: A potential adjuvant therapy for cancer patients receiving chemotherapeutic mAbs.
Christopher N Subasic, Fiona Simpson, Rodney F Minchin, Lisa M Kaminskas

Nanomedicine· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipidated brush-PEG polymers as low molecular weight pulmonary drug delivery platforms.
Lisa M Kaminskas, Neville J Butcher, Christopher N Subasic, Ashok Kothapalli, Shadabul Haque

Expert Opin Drug Deliv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of endogenous albumin trafficking pathways in the lungs has potential to modestly increase the lung interstitial access and absorption of drug delivery systems after inhaled administration.
Jibriil P Ibrahim, Neville J Butcher, Ashok Kothapalli, Christopher N Subasic, Joanne T Blanchfield

Expert Opin Drug Deliv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-Dependent Effect of Phenothiazines as Dynamin II Inhibitors on the Uptake of PEGylated Liposomes by Endocytic Cells and In Vivo Pharmacokinetics of PEGylated Liposomal Doxorubicin in Rats.
Christopher N Subasic, Neville J Butcher, Fiona Simpson, Rodney F Minchin, Lisa M Kaminskas

Mol Pharm· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats.
Christopher N Subasic, Neville J Butcher, Rodney F Minchin, Lisa M Kaminskas

Mol Pharm· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a hyperbranched polymer-based methotrexate nanomedicine for rheumatoid arthritis.
Nirmal Marasini, Gerald Er, Changkui Fu, Christopher N Subasic, Jibriil Ibrahim

Acta Biomater· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly(HPMA-co-NIPAM) copolymer as an alternative to polyethylene glycol-based pharmacokinetic modulation of therapeutic proteins.
Christopher N Subasic, Aditya Ardana, Linda J Chan, Fei Huang, Judith A Scoble

Int J Pharm· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetics of PEGylated liposomal doxorubicin are not significantly affected by sex in rats or humans, but may be affected by immune dysfunction.
Christopher N Subasic, Esther Kuilamu, Gary Cowin, Rodney F Minchin, Lisa M Kaminskas

J Control Release· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Polymer Size and Cleavability on the Intravenous Pharmacokinetics of PEG-Based Hyperbranched Polymers in Rats.
Nirmal Marasini, Changkui Fu, Nicholas L Fletcher, Christopher Subasic, Gerald Er

Nanomaterials (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab Exhibits Sex Differences in Lymphatic Exposure after Intravenous Administration in Rats in the Absence of Differences in Plasma Exposure.
Esther Kuilamu, Christopher Subasic, Gary J Cowin, Fiona Simpson, Rodney F Minchin

Pharm Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug formulation and nanomedicine approaches to targeting lymphatic cancer metastases.
Lili Wang, Christopher Subasic, Rodney F Minchin, Lisa M Kaminskas

Nanomedicine (Lond)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis